At the news
? NEUTRALIMPACT 2/10 144 filed Sep 11, 2026 at 15:14 ET
Charles Divita, a Director and Officer of Teladoc Health, filed a Form 144 notice of intent to sell 17,805 shares of common stock, with an estimated aggregate market value of approximately $108,684. The shares were acquired on September 10, 2026, through restricted stock vesting as compensation. The filing is a routine notice of intent to sell shares to cover tax obligations from equity vesting, and does not signal a change in the insider's view of the company's prospects.
- Director and Officer Charles Divita filed a Form 144 to sell 17,805 shares of common stock.
- The estimated aggregate market value of the proposed sale is approximately $108,683.50.
- The shares were acquired on September 10, 2026, via restricted stock vesting as compensation.
- The filing notes the sale is to cover a tax obligation from the settlement of a vested equity award.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access